2-Methylbenzimidazole → HCID 49785640, compound
Reaction equation
Br[C:2]1[CH:7]=[C:6]([C:8]([C:10]2[NH:14][C:13]3[CH:15]=[C:16]([N:19]4[CH2:24][CH2:23][CH:22]([N:25]([CH3:27])[CH3:26])[CH2:21][CH2:20]4)[CH:17]=[CH:18][C:12]=3[N:11]=2)=[O:9])[CH:5]=[CH:4][N:3]=1.[CH3:28][C:29]1[NH:30][C:31]2[CH:37]=[CH:36][CH:35]=[CH:34][C:32]=2[N:33]=1.CN[C@@H]1CCCC[C@H]1NC>CN(C=O)C.CCOC(C)=O.[Cl-].[Na+].O.[Cu]I>[CH3:26][N:25]([CH3:27])[CH:22]1[CH2:23][CH2:24][N:19]([C:16]2[CH:17]=[CH:18][C:12]3[N:11]=[C:10]([C:8]([C:6]4[CH:5]=[CH:4][N:3]=[C:2]([N:30]5[C:31]6[CH:37]=[CH:36][CH:35]=[CH:34][C:32]=6[N:33]=[C:29]5[CH3:28])[CH:7]=4)=[O:9])[NH:14][C:13]=3[CH:15]=2)[CH2:20][CH2:21]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 4
Conditions
- Temperature
- 130 °C
Procedure
A mixture of (2-bromo-pyridin-4-yl)-[6-(4-dimethylamino-piperidin-1-yl)-1H-benzoimidazol-2-yl]-methanone (0.46 mmol, 1.0 mol eq.) [Example 102 (Method 1, Step 3)], 2-methyl benzimidazole (0.56 mmol, 1.2 mol eq), CuI (0.047 mmol, 0.5 mol eq.), (1R,2R)—N,N′-dimethyl-cyclohexane-1,2-diamine (0.093 mmol, 0.2 mol eq.) in 2 mL of DMF was heated at 130° C. for 48 h under nitrogen. The reaction was diluted with 50 mL EtOAc and 50 mL brine. The organic layer was separated and dried over Na2SO4, filtered and evaporated to dryness. HPLC purification gave the title compound (31 mg, 14%). HRMS m/z 480.2502 (M+H)+. 1H NMR (400 MHz, DMSO-d6): 8.96 (1H, d), 8.65 (1H, s), 8.30 (1H, d), 7.74-7.63 (3H, m), 7.31-7.29 (2H, m), 7.17 (1H, d), 6.93 (1H, s), 4.16 (1H, bs), 3.77-3.74 (2H, m), 2.80-2.71 (2H, m), 2.70 (3H, s), 2.20 (6H, s), 1.89-1.85 (2H, m), 1.57-1.48 (2H, m).
Workup
- customThe organic layer was separated
- dry with materialdried over Na2SO4
- filtrationfiltered
- customevaporated to dryness
- customHPLC purification
Sources & evidence
- ORD record
- ord-66d01852ce5541aab92c7c7a6cd323dc
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08598217B2
Reaction notes
Loading…